#US pharma trade organisation #PhRMA is challenging the #Trump administration's #GLOBE model for Most-Favoured Nation (#MFN) #pricing in #Medicare Part B in court, accusing it of government overreach.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social
@g064.bsky.socialThis the beginning of the end. #MFN #myfriendlyneighborhood #indiegame
@andrei8iordache.bsky.socialPharma price referencing map across European countries. The web of interconnectedness seems daunting in the context of #MFN.
source: pubmed.ncbi.nlm.nih.gov/27123181/
@g064.bsky.social@andrei8iordache.bsky.social𧡠Interesting #pharma_pricing details in the #MFN agreements (Pfizer & Lilly): ππ’π¦π’π§π , π π π«ππππ¬ & π’π§ππ₯πππ’π¨π§ π‘πππ ππ¬.
ππ’π¦π’π§π ππ’ππ ππ¨ US ππ«ππ¬π’πππ§ππ’ππ₯ ππ₯ππππ’π¨π§π¬ The Pfizer agreement expires 31DEC2028, a few days before the next US President will be sworn in. Lilly's agreement has it blacked out. 1/5
@4040rec.bsky.social